As the global population of adults aged over 60 years increases rapidly, the burden of infectious respiratory diseases such as COVID-19, respiratory syncytial virus, and influenza presents an urgent challenge. In an insightful interview, three leading experts explored the evolving landscape of these diseases, discussing risk factors, prevention strategies, and barriers to effective vaccination.
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.